Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Mustafa Karaca; Mustafa Serkan Alemdar; Özge Deniz Karaca; Yıldız Kılar; Gökhan Köker; Hasan Sözel; Mustafa Yıldız; Gülhan Özçelik Köker; Mustafa Özgür Arici

doi:10.12659/MSM.945240

26 November 2024 : Clinical Research

Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Mustafa Karaca^1ACDEF, Mustafa Serkan Alemdar^2BDF, Özge Deniz Karaca^3ABEF, Yıldız Kılar^4BD, Gökhan Köker^3BEF, Hasan Sözel^5CDE, Mustafa Yıldız^2DEF, Gülhan Özçelik Köker^1DEF, Mustafa Özgür Arici

^2BDEF*

DOI: 10.12659/MSM.945240

Med Sci Monit 2024; 30:e945240

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Comparison of clinical characteristics by sarcopenia status.

		Absent		Present		P
		n	%	n	%	P

	Mean±SD	49.47±11.79		51.63±10.40		0.224
	Premenopausal	77	45.3	23	41.1	0.581
	Postmenopausal	93	54.7	33	58.9	0.581
	<30	76	44.7%	0	0%
	≥30	94	55.3%	56	100%

	Mean±SD	48.83±11.69		51.72±11.0		0.063
	Premenopausal	64	47.8	36	39.1	0.199
	Postmenopausal	70	52.2	56	60.9	0.199
	<30	76	56.7%	0	0%
	≥30	58	43.3%	92	100%
NAC – neoadjuvant chemotherapy; SD – standard deviation; BMI – body mass index. values indicate statistical significance.

Back to the Article

Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Your Privacy